UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Preoperative weekly cisplatin–epirubicin–paclitaxel with G-CSF support in triple-negative large operable breast cancer

Annals of oncology, 2009-07, Vol.20 (7), p.1185-1192

2009

Volltextzugriff (PDF)

The impact of adjuvant and neo-adjuvant therapies on one - stage breast reconstruction with TiLOOP Bra

Breast (Edinburgh), 2017-03, Vol.32, p.S113-S113

2017

Volltextzugriff (PDF)

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908

Annals of oncology, 2010-04, Vol.21 (4), p.707-716

2010

Volltextzugriff (PDF)

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)

Annals of oncology, 2007-02, Vol.18 (2), p.324-330

2007

Volltextzugriff (PDF)

Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer : final analysis of a sicog phase III study

British journal of cancer, 2006-10, Vol.95 (8), p.1005-1012

2006

Volltextzugriff (PDF)

Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients

British journal of cancer, 2004-08, Vol.91 (3), p.489-497

2004

Volltextzugriff (PDF)

A 2-month cisplatin–epirubicin–paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study

Annals of oncology, 2005-08, Vol.16 (8), p.1268-1275

2005

Volltextzugriff (PDF)

P274 - The impact of adjuvant and neo-adjuvant therapies on one - stage breast reconstruction with TiLOOP Bra

Breast (Edinburgh), 2017-03, Vol.32, p.S113-S113

2017

Volltextzugriff (PDF)

Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2000-07, Vol.18 (13), p.2529-2536

2000

Volltextzugriff (PDF)

Chemotherapy of lung cancer in the elderly

Critical reviews in oncology/hematology, 2002-03, Vol.41 (3), p.349-361

Frasci, Giuseppe

2002

Volltextzugriff (PDF)

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study

Annals of oncology, 2000-03, Vol.11 (3), p.367-371

2000

Volltextzugriff (PDF)

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

British journal of cancer, 2001-05, Vol.84 (9), p.1166-1171

2001

Volltextzugriff (PDF)

Outcome Analysis of Breast Cancer Patients Receiving Breast-Conserving Surgery in Southern Italy

Journal of chemotherapy (Florence), 2008-04, Vol.20 (2), p.269-277

2008

Volltextzugriff (PDF)

Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study

Annals of oncology, 1999-03, Vol.10 (3), p.355-358

1999

Volltextzugriff (PDF)

Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group

Journal of clinical oncology, 2000-04, Vol.18 (7), p.1451-1457

2000

Volltextzugriff (PDF)

Treatment of breast cancer with chemotherapy in combination with filgrastim: Approaches to improving therapeutic outcome

Drugs (New York, N.Y.), 2002, Vol.62 (Supplement 1), p.17-31

FRASCI, Giuseppe

2002

Volltextzugriff (PDF)

Genetic counseling in breast cancerThe National Cancer Institute of Naples experience

European journal of cancer supplements, 2008, Vol.6 (7), p.74-74

2008

Volltextzugriff (PDF)

Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOQ) phase II study

Breast cancer research and treatment, 2000-07, Vol.62 (2), p.87-97

2000

Volltextzugriff (PDF)

Additional Safety Results of Hannah: A Phase III Randomised, Open-Label, International Study of the Subcutaneous Formulation of Trastuzumab (H) in HER2-Positive Early Breast Cancer Patients

Annals of oncology, 2012-09, Vol.23, p.ix102-ix103

2012

Volltextzugriff (PDF)

Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1409-1417

1997

Volltextzugriff (PDF)

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial

British journal of cancer, 1996-12, Vol.74 (11), p.1805-1811

1996

Volltextzugriff (PDF)

Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: A phase I study

Annals of oncology, 1997-10, Vol.8 (10), p.1045-1048

1997

Volltextzugriff (PDF)

Gemcitabine/Cyclophosphamide/5-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients: A Southern Italy Cooperative Oncology Group Phase I/II Study

Seminars in oncology, 2001-06, Vol.28 (3), p.50-56

2001

Volltextzugriff (PDF)

Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients

European journal of cancer (1990), 1998-10, Vol.34 (11), p.1710-1714

1998

Volltextzugriff (PDF)

Relapse in breast cancer: How much mode of breast cancer detection matters? Results from an Italian national cancer institute

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e12012-e12012

2011

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(120)
Tagungsberichte
(2)

Sprache

Englisch
(122)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preoperative weekly cisplatin–epirubicin–paclitaxel with G-CSF support in triple-negative large operable breast cancer

The impact of adjuvant and neo-adjuvant therapies on one - stage breast reconstruction with TiLOOP Bra

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)

Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer : final analysis of a sicog phase III study

Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients

A 2-month cisplatin–epirubicin–paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study

P274 - The impact of adjuvant and neo-adjuvant therapies on one - stage breast reconstruction with TiLOOP Bra

Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

Chemotherapy of lung cancer in the elderly

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

Outcome Analysis of Breast Cancer Patients Receiving Breast-Conserving Surgery in Southern Italy

Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study

Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group

Treatment of breast cancer with chemotherapy in combination with filgrastim: Approaches to improving therapeutic outcome

Genetic counseling in breast cancerThe National Cancer Institute of Naples experience

Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOQ) phase II study

Additional Safety Results of Hannah: A Phase III Randomised, Open-Label, International Study of the Subcutaneous Formulation of Trastuzumab (H) in HER2-Positive Early Breast Cancer Patients

Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial

Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: A phase I study

Gemcitabine/Cyclophosphamide/5-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients: A Southern Italy Cooperative Oncology Group Phase I/II Study

Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients

Relapse in breast cancer: How much mode of breast cancer detection matters? Results from an Italian national cancer institute

Suchergebnisse filtern